Pamela A. Borgess, a partner at Zoll, Kranz and Borgess, practices in pharmaceutical and medical device litigation, as well as other class actions/mass tort, medical/professional malpractice, personal injury, and wrongful death cases. 

   Ms. Borgess and her firm received national attention, when they were the first to file suit regarding the tainted heparin sold from China that took the lives of hundreds of innocent Americans in late 2007 and early 2008. In April of 2008, they were honored to have three of their clients speak before Congress at an investigational hearing entitled, “The Heparin Disaster: Chinese Counterfeits and American Failures.” Their stories have also been featured in news media, including, but not limited to, ABC Nightly News, Nightline, Time Magazine, CNN and Bloomberg News. As a result of their work in heparin, the firm was appointed a top leadership position in Heparin MDL 1953 and is currently leading that litigation against Baxter, SPL and other Defendants.

   Ms. Borgess and her firm were also one of the first to file suit in 2009 regarding the birth control drugs, Yasmin and Yaz, and are playing a leadership role in that national litigation as well. She has also been involved with In re: Inter-Op Hip Prosthesis Liability Litigation (Sulzer) MDL Docket No. 01-CV-9000, In re: Vioxx® Products Liability Litigation MDL Docket No. 1657, Ford Crown Victoria, Bextra/Celebrex, and other mass tort litigation projects.

   Ms. Borgess has been honored both nationally and locally. She has been repeatedly invited to speak on the heparin litigation and other topics at the annual national conventions held by the American Association for Justice (“AAJ”) and Mass Torts Made Perfect. In 2009, AAJ honored Ms. Borgess by asking her to act as moderator for their annual “Litigating Toxic Tort, Pharmaceutical and Medical Cases” seminar.

   Locally, Ms. Borgess has served as Chair of the Toledo Bar Association's Lawyer/Doctor Committee and has helped organize the committee's annual continuing legal and medical education seminar for physicians and lawyers. In 2006, Ms. Borgess was one of five appointees of a joint conference committee assigned to revise the Toledo Bar Association's Statement of Principles Governing Physician-Lawyer Relationships. 

   Ms. Borgess has also been invited to speak and act as moderator for multiple local legal and medical seminars on a variety of medical/legal topics, including trial practice, expert testimony, medical records, termination of the physician-patient relationship, sexual misconduct and harassment in the practice of medicine, Ohio's "Good Samaritan" and related laws, physician censure for expert witness testimony, and legal/medical ethics.